HCT 9.09% 2.0¢ holista colltech limited

All the bases are covered, page-293

  1. 4,913 Posts.
    lightbulb Created with Sketch. 822
    I have been looking at ZNO vs HCT, and here is some break ups i can see.

    for the October- Dec quater
    ZNO
    opened in October share price 9c
    closed in Dec share price 76.5c
    turnover for quarter 589K
    no mention of Covid 19
    share price increase 850%

    HCT
    opened in October 6.8c
    closed December 8c
    turnover for quarter 2.3 million, cash positive
    no mention of covid 19
    share price increase 17.6%

    The share prices have continued to get further apart, what happens if we have a turn-over of more then ZNO this quarter? and our SP remains subdued, and ZNO continues to grow,

    what am i missing, i understand we have approx 100 million more shares on offer, so ok like for like based on the oct-dec quarter, either we ZNO should be approx 13c if based on our price, or we should be somewhere around 50c if we use ZNO's price, remembering we turned over 5 times as much as ZNO for the quarter and were cash positive.

    There is something very odd going on with HCT's price suppression, either that or ZNO is massively over valued, current market values given
    HCT 18.8c
    ZNO $1.99
    so ZNO is worth 10.5 times that of HCT, based on what, someone show me the logic behind this? and lets not forget this was very similar at the end of the oct-dec quarter, ZNO was worth 9.5 time what HCT was, only turned over 580K and was cash negative?????
    note these numbers were rushed and will not be even close to 100% accurate.
 
watchlist Created with Sketch. Add HCT (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
-0.002(9.09%)
Mkt cap ! $5.576M
Open High Low Value Volume
2.2¢ 2.2¢ 2.0¢ $3.316K 156.1K

Buyers (Bids)

No. Vol. Price($)
1 37641 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 12359 1
View Market Depth
Last trade - 10.52am 13/09/2024 (20 minute delay) ?
HCT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.